ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1153

Coexistence of Acute Cellular Allograft Rejection and Extrarenal Recurrence of p-ANCA Vasculitis After Kidney Transplantation

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Alsaedi, Zainulabdeen S., Washington University in St Louis, Saint Louis, Missouri, United States
  • Gomide Almeida, Guilherme, Washington University in St Louis, Saint Louis, Missouri, United States
  • Khan, Muhammad Ulusyar, Washington University in St Louis, Saint Louis, Missouri, United States
  • Alrata, Louai, Washington University in St Louis, Saint Louis, Missouri, United States
  • Messias, Nidia Cordeiro, Washington University in St Louis, Saint Louis, Missouri, United States
  • Merzkani, Massini, Washington University in St Louis, Saint Louis, Missouri, United States
  • Paul, Rohan Singh, Washington University in St Louis, Saint Louis, Missouri, United States
  • Murakami, Naoka, Washington University in St Louis, Saint Louis, Missouri, United States
Introduction

We report a rare case of simultaneous acute cellular rejection (ACR) of a renal allograft and isolated pulmonary recurrence of P ANCA MPO associated vasculitis presenting as diffuse alveolar hemorrhage (DAH), without renal vasculitis on biopsy

Case Description

A 25 year old female with ESRD from biopsy proven ANCA associated crescentic GN who underwent DDKT before 4 years (0/6 HLA MM, KDPI 36%, cPRA 0%). She received rATG induction and was maintained on tacrolimus, azathioprine and prednisone, with persistently low P ANCA
She presented with severe non oliguric AKI after self discontinuing tacrolimus. She was markedly hypertensive; renal US showed no renal artery stenosis or obstruction. Labs are shown in the table
Allograft biopsy showed Banff IB TCMR with no recurrent ANCA vasculitis. She was treated with pulse steroids and rATG (3 mg/kg). After the first rATG dose, she developed hemoptysis and respiratory distress requiring ICU care. Imaging suggested pulmonary edema, but bronchoscopy confirmed DAH

Discussion

ANCA vasculitis recurrence usually involves the allograft. However, this case shows an unusual isolated pulmonary relapse occurring with TCMR. The onset soon after rATG suggests possible cytokine mediated reactivation. A high index of suspicion is required when vasculitis is absent on renal biopsy

Laboratory Findings

A. PAS: Normal glomerulus without crescents; tubules with severe tubulitis
B & C. H&E: Tubulointerstitial inflammation without vascular inflammation